Crossmark

Contribution of CRISPR/Cas9 technology in gene editing and its potential therapeutic benefits in combating antimicrobial-resistant bacteria: a narrative review

Crossref DOI link: https://doi.org/10.1007/s42452-026-08632-y

Published Online: 2026-03-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Teffera, Zigale Hibstu

Tegegne, Bantayehu Addis

Adugna, Adane

Belew, Habtamu

Amare, Gashaw Azanaw

Abebaw, Desalegn

Atnaf, Aytenew

Shitie, Bewket Misganaw

Enchalew, Kassaye

Belay, Wubetu Yihunie

Jemal, Mohammed

Ashenef, Baye

Getinet, Mamaru

Hibistu, Tiruzer

Berhan, Ayenew
License Information

Text and Data Mining valid from 2026-03-31

Version of Record valid from 2026-05-27
More Information

Article History

Received: 30 July 2025

Accepted: 27 March 2026

First Online: 31 March 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below